London and Boston (OTE) - Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines.
London (OTE) - Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline.
London (OTE) - Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline.